Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details Narrative)

v3.23.1
Stockholders’ Equity (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended
Mar. 31, 2022
Feb. 28, 2022
Jan. 31, 2022
Aug. 31, 2021
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Subsidiary, Sale of Stock [Line Items]              
Common Stock shares, Outstanding         15,016,295   15,016,295
Proceeds from Warrant Exercises         $ 1  
Stock-based compensation         $ 290 $ 253  
Common Stock [Member]              
Subsidiary, Sale of Stock [Line Items]              
Issuance of common stock, net (in shares)           1,151,000  
Common Stock [Member] | Restricted stock agreement with Maxim Group, LLC [Member]              
Subsidiary, Sale of Stock [Line Items]              
Number of shares agreed to issue       50,000      
Vesting period       12 months      
Stock-based compensation           $ 27  
JT Pharmaceuticals [Member]              
Subsidiary, Sale of Stock [Line Items]              
Issuance of common stock, net (in shares)     51,021        
Milestone Payment     $ 100,000        
Pre-Funded Warrants [Member]              
Subsidiary, Sale of Stock [Line Items]              
Number of warrants issued 974,242         974,242  
Proceeds from Warrant Exercises $ 1            
February 2022 Offerings [Member]              
Subsidiary, Sale of Stock [Line Items]              
Issuance of common stock, net (in shares)   1,100,000          
Proceeds from sale of common stock   $ 5,000          
February 2022 Offerings [Member] | Pre-Funded Warrants [Member]              
Subsidiary, Sale of Stock [Line Items]              
Number of warrants issued   2,274,242          
Exercise price of warrants (in dollars per share)   $ 0.001          
February 2022 Offerings [Member] | Unregistered prefunded warrants [Member]              
Subsidiary, Sale of Stock [Line Items]              
Number of warrants issued   1,289,796          
Exercise price of warrants (in dollars per share)   $ 0.001          
February 2022 Offerings [Member] | Unregistered five year and six month warrants [Member]              
Subsidiary, Sale of Stock [Line Items]              
Number of warrants issued   4,664,038          
Exercise price of warrants (in dollars per share)   $ 1.14